Novavax Inc. buy quelbe60
Start price
12.12.21
/
50%
€151.40
Target price
12.12.22
-
Performance (%)
5.67%
End price
25.12.21
€159.98
Summary
This prediction ended on 25.12.21 with a price of €159.98. With a performance of 5.67%, the BUY prediction by quelbe60 for Novavax Inc. closed with a slight gain. quelbe60 has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Novavax Inc. | -8.867% | -8.867% | 43.604% |
iShares Core DAX® | 1.665% | 1.692% | 18.093% |
iShares Nasdaq 100 | -0.475% | 1.483% | 27.860% |
iShares Nikkei 225® | 2.620% | 4.475% | 17.651% |
iShares S&P 500 | -0.091% | 1.099% | 24.873% |
According to quelbe60 what are the pros and cons of Novavax Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by quelbe60 for this prediction
In the thread Novavax Inc. diskutieren
Buy Novavax Inc.
In the thread Trading Novavax Inc.
Buy beendet
Stopped prediction by quelbe60 for Novavax Inc.
Novavax Inc.
Start price
Target price
Perf. (%)
€3.75
29.01.24
29.01.24
-
29.01.25
29.01.25
-2.03%
03.02.24
03.02.24
Could be very worthwhile Investment >20% year
Novavax Inc.
Start price
Target price
Perf. (%)
€6.62
01.03.23
01.03.23
-
01.03.24
01.03.24
-15.51%
17.03.23
17.03.23
Could be very worthwhile Investment >20% year
Novavax Inc.
Start price
Target price
Perf. (%)
€74.55
23.01.22
23.01.22
-
23.01.23
23.01.23
7.12%
06.02.22
06.02.22
Could be very worthwhile Investment >20% year